Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.
about
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complicationsGut microbiota and liver diseasesImplication of the intestinal microbiome in complications of cirrhosisGut Microbiota and Host Reaction in Liver DiseasesHost genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiotaAn analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection.Linking intestinal homeostasis and liver disease.Microbiota-liver axis in hepatic disease.Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.The role of microbiota in hepatic encephalopathyMicrobiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.The gut microbiota and the liver: implications for clinical practice.Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients.Altered profile of human gut microbiome is associated with cirrhosis and its complications.The relevance of intestinal dysbiosis in liver transplant candidates.Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathyObesity in school-aged children and its correlation with gut E.coli and Bifidobacteria: a case-control study.Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitisThe gut microbiota and liver disease.Human Microbiome and its Association With Health and Diseases.Toll-like receptors in liver fibrosis: cellular crosstalk and mechanismsStool vs. Serum Hepatitis B Virus DNA in Patients with Chronic Hepatitis B.Probiotics and liver diseaseRisk factors and outcome of bacterial infections in cirrhosisRole of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature.Interactions between the intestinal microbiome and liver diseases.Probiotics for people with hepatic encephalopathy.Interplay between viruses and bacterial microbiota in cancer development.Dietary l-arginine inhibits intestinal Clostridium perfringens colonisation and attenuates intestinal mucosal injury in broiler chickens.Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.Assessment of microbiome variation during the perioperative period in liver transplant patients: a retrospective analysis.Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats.HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.Effect of diclazuril on intestinal morphology and SIgA expression in chicken infected with Eimeria tenella.The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma.Assessment of the fecal lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant.
P2860
Q26775927-9AA806E1-11AB-497A-B918-0C47387C0E87Q27015127-52F34389-7867-41BC-8DB7-17E5B4FFFE7EQ28068832-8E0E06ED-B3B6-4E15-88F2-5AC4B2A22D45Q28083295-30C5333B-EB1D-4C85-BF6B-90F8A794B8FCQ28732754-C85F80C0-4192-40FC-9AEC-16B16CAFDA3CQ31170809-53259420-0E12-438A-AAE2-85D8C82FFBB4Q33828940-D7DCAEE1-7FE4-4178-A6FA-3D02135FC9D2Q33855414-8C415D0A-37D7-4A4A-BB67-8EC32F7B9B93Q33981675-FCC72231-E0D8-44FC-9DE0-ABA913B930FAQ34129402-DE49D1B3-EB10-464F-B852-22C8C0052ECDQ34647371-D44E24B1-86BD-4043-AA3C-9FE3438AC05FQ35019661-4101112C-2554-4E61-9982-5E9CF10424ADQ35034053-DACF6CDD-01F3-49DC-A052-CD780FC2B15DQ35077209-0C3AA01A-150F-4C34-9822-E839FF3648A1Q35569791-A7ED4DB9-1FF8-449A-8BE1-C0FFA7909215Q35589590-9D5AA54F-2B2A-4AFD-B469-D131110548A8Q35646490-87F69557-806D-45D5-81E1-2DB0FD15D2FAQ35697286-2955F757-3630-41B5-AAFB-3E7BAC9C47A5Q35743960-8DF82EEF-E7A5-4CFB-8499-372701CE6B69Q35867582-7905A668-A140-4C56-BE22-A71F37109F4DQ35977675-D44F82C8-BF37-44DA-B737-89211ACB38CAQ36368210-0C008ECE-BAD4-4BE0-8912-32BEAE21D8A8Q37372411-4AC734DB-976A-4103-95F7-D857950868C6Q37629681-EDA7EBFC-5A6F-4A08-B310-988C5762319BQ37962297-0E48269B-6783-43EA-AC7C-C184377A88BEQ38074434-ADF323CD-2AD7-4840-A5CD-9CBD4FD18785Q38123531-DE65D301-18D2-471D-ADB8-99D4C22CCFFAQ38179779-60C73088-8B28-4D49-A79A-F76A7B4BE437Q38946102-400FD7E3-D69D-4369-A6E7-2F80F8FB7E6BQ39365350-8E89955A-9962-4954-BE5F-9E0896360971Q40049512-39EA9692-A063-48BC-B50C-30ED94EA7239Q40087509-812B5F29-6FB9-40D0-A6C5-8EA5DFBB3C8DQ40098743-DB32BD5C-C867-4D6D-8E82-D166A6557811Q40112427-B2B7DD90-189C-490A-AEA2-EF28505368ABQ40612995-10542671-7B72-4488-83BC-00355713E6C4Q40880190-83E08F1A-CA72-4E63-9AE7-332D6A8D6F17Q41706834-A93776F4-3AA9-4DCA-B657-B9506637DBDDQ42198119-90BB409B-2DB6-4B71-A080-9B6DE2F71E37Q44987249-520B234B-80A4-473C-83B8-80F72052ABD1Q45362841-D8597645-0BAE-4E37-A98F-B4A9F0C04F97
P2860
Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Intestinal microbiota was asse ...... ota of HBV cirrhotic patients.
@en
Intestinal microbiota was asse ...... ota of HBV cirrhotic patients.
@nl
type
label
Intestinal microbiota was asse ...... ota of HBV cirrhotic patients.
@en
Intestinal microbiota was asse ...... ota of HBV cirrhotic patients.
@nl
prefLabel
Intestinal microbiota was asse ...... ota of HBV cirrhotic patients.
@en
Intestinal microbiota was asse ...... ota of HBV cirrhotic patients.
@nl
P2093
P2860
P1433
P1476
Intestinal microbiota was asse ...... ota of HBV cirrhotic patients.
@en
P2093
Haifeng Lu
Jiezuan Yang
Lanjuan Li
Yunbo Chen
Zhongwen Wu
P2860
P2888
P304
P356
10.1007/S00248-010-9801-8
P577
2011-02-01T00:00:00Z